Thermo Fisher, BioAnalytix to Develop Platforms, Applications for Biologics Characterization | GenomeWeb

NEW YORK (GenomeWeb) – Thermo Fisher Scientific and BioAnalytix today announced they will develop advanced analytical profiling platforms and applications for characterizing biologic and biosimilar drugs.

Minor differences in the structures of biological drugs can significantly affect their safety and efficacy, and sophisticated analytic workflows are necessary for accurate characterization. Thermo Fisher and BioAnalytix aim to develop analytical profiling standards in order to support and accelerate the development of such therapeutics, they said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: certain genes repressed during memory formation, analysis of genomes from single neurons, and more.

NASA plans to test whether DNA sequencing studies can be conducted in microgravity.

Congress passes a continuing resolution to keep the US federal government funded through mid-December.

The Human Genome Project was launched 25 years ago, and at Nature, Francis Collins, James Watson, and Eric Green look back at the lessons learned.